| Literature DB >> 22619485 |
Xianbao Liu1, Hong Zhan, Xu Zeng, Chunfang Zhang, Dunjin Chen.
Abstract
In the present study, we assessed the treatment effects of PBDE-209 administration on the immune function in rats during pregnancy and lactation. We harvested the blood and organs for flow cytometry, viability assay, enzyme-linked immunosorbent assay, and histological evaluation. The results of this study were the PBDE-209 exposure during pregnancy and lactation impairs immune function in rats. The results may contribute to understanding the mechanism of PBDE-209 in immune function.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22619485 PMCID: PMC3349269 DOI: 10.1155/2012/692467
Source DB: PubMed Journal: Mediators Inflamm ISSN: 0962-9351 Impact factor: 4.711
Weight of body and organs (g).
| Detection index | Control group | Experimental group |
|---|---|---|
| rat weight | 284.00 ± 23.98 | 251.24 ± 32.73* |
| thymic weight | 0.21 ± 0.03 | 0.20 ± 0.03 |
| thymus index number | 0.75 ± 0.10 | 0.80 ± 0.11 |
| spleen weight | 0.67 ± 0.04 | 0.75 ± 0.03** |
| spleen index number | 2.37 ± 0.19 | 3.00 ± 0.30** |
Mean ± standard deviation, *P < 0.05, **P < 0.01.
Figure 1We measured the percentage of T lymphocytes in blood of exposed Sprague-Dawley (SD) rats using flow cytometric analysis. Values are expressed as mean ± standard deviation, and are representative of two separate experiments with twenty rats per group in each experiment. *P < 0.05 compared to control group.
IgM, IgG, IFN-γ, and IL-4 levels in serum as measured by enzyme-linked immunosorbent assay and percentage of NK cells with CD161 surface markers.
| Group | IgM ( | IgG ( | IFN- | IL-4 (pg/mL) | CD161+ (%) |
|---|---|---|---|---|---|
| Control group | 6.06 ± 1.51 | 17.02 ± 0.67 | 22.57 ± 20.47 | 16.07 ± 4.17 | 12.05 ± 0.88 |
| Experimental group | 4.36 ± 1.49* | 16.31 ± 0.45* | 12.27 ± 14.96 | 15.53 ± 3.63 | 6.23 ± 1.33** |
Mean ± standard deviation, *P < 0.05, **P < 0.01.
T and B lymphocytes OD value.
| Group | OD with PHA (LPS) stimulus | OD with no PHA (LPS) stimulus | OD stimulus index |
|---|---|---|---|
| Control group | 0.87 ± 0.11 | 0.26 ± 0.09 | 3.55 ± 0.97 |
| (1.29 ± 0.48) | (1.03 ± 0.48) | (1.21 ± 0.04) | |
| Experimental group | 0.70 ± 0.17* | 0.42 ± 0.10** | 1.69 ± 0.20** |
| (0.57 ± 0.11**) | (0.31 ± 0.12**) | (1.80 ± 0.33*) |
Mean ± standard deviation, *P < 0.05, **P < 0.01.
Figure 2(a)–(o). Histological examination of microphotographs obtained from the tissues of twenty animals in each group revealed changes in the architecture of thymus, spleen, ovaries, and liver of treated (0.3 mg/kg/d) animals. Thymus: (a) experimental group (200X); connective tissues (arrow); (b) experimental group (100X);connective tissues (arrow); (c) control group (200X), corticomedullary (green arrow) thymic corpuscles (black arrow); (d) control group (100X); Spleen: (e) experimental group (200X); (f) experimental group (400X); (g) control group (200X), fibrous connective tissue(arrow); (h) control group (100X). Ovaries: (i) experimental group (200X), follicular atresia (arrow); (j) experimental group (100X); (k) control group (200X), follicular (arrow); (l) control group (100X); Liver: (m) experimental group (200X), eosinophilic bodies (blue arrow), ballooned change (green arrow); (n) central vein (arrow) experimental group (100X); (o) control group (200X), eosinophil (arrow); (p) control group (100X).
Histological scoring of thymus, spleen, ovaries, and liver injury.
| Group | Thymus | Spleen | Ovaries | Liver |
|---|---|---|---|---|
| Control group | ND | ND | ND | ND |
| Experimental group | 2.5 ± 0.20** | 2.3 ± 0.15** | 3.1 ± 0.16** | 3.5 ± 0.13** |
ND: not detectable, mean ± standard deviation, Mean ± standard deviation, *P < 0.05, **P < 0.01.